Synthesis and Pharmacological Evaluation of N-Substituted Arylsulfonamide Derivatives asNew γ-Secretase Inhibitors
碩士 === 國防醫學院 === 藥學研究所 === 99 === Alzheimer’s disease (AD) is an irreversible, progressive neurodegenerative disease characterized by beta-amyloid (Aβ) deposition and neurofibrillary tangles (NFTs) formation. The overproduction and accumulation of Aβ are key pathogenic events in AD progression. Aβ i...
Main Authors: | Chen, Chia-Yu, 陳佳瑜 |
---|---|
Other Authors: | Hu, Ming-Kuan |
Format: | Others |
Language: | zh-TW |
Published: |
2011
|
Online Access: | http://ndltd.ncl.edu.tw/handle/00797993498231743572 |
Similar Items
-
Synthesis and Pharmacological Evaluation of N-Arylsulfonamide Derivatives as New γ-Secretase Inhibitors
by: Chang Yu-Yuan, et al.
Published: (2010) -
Synthesis and Pharmacological Evaluation of Peptide-Derivedγ-secretase Inhibitors
by: Shin-Ya Huang, et al.
Published: (2004) -
Synthesis and Pharmacological Evaluation of Amino Acid-Derived and Peptidomimetic γ-secretase Inhibitors
by: 廖笳因
Published: (2004) -
γ-Secretase Pharmacology: What Pharmacology Will Work for Alzheimer's Disease?
by: Jeremy H. Toyn, et al.
Published: (2013-01-01) -
Semagacestat Is a Pseudo-Inhibitor of γ-Secretase
by: Shinji Tagami, et al.
Published: (2017-10-01)